Major Players in Israel’s Cannabis Industry
The cannabis industry in Israel is a hub of innovation and research, with the country being one of the pioneers in medical cannabis research and biotechnology. Israel’s position in the cannabis industry is unique due to its favorable government policies, advanced agricultural technology, and a robust scientific community.
Research and Development
Israel’s prominence in the industry began with the groundbreaking research of Prof. Raphael Mechoulam from the Hebrew University of Jerusalem, who is often referred to as the “father of cannabis research.” He was the first to isolate THC, the psychoactive compound in cannabis. This early research laid the groundwork for the burgeoning medical cannabis industry in Israel.
Government Policy
The Israeli government has progressively taken steps to decriminalize cannabis and support medical cannabis research and business initiatives. In 2016, the government approved new regulations to ease the restrictions on growing, manufacturing, and exporting medical cannabis. This move opened up international business prospects for Israeli companies.
Medical Cannabis
Israel’s Ministry of Health oversees the medical cannabis unit, which is responsible for patients’ licensing and regulation of the medical cannabis industry. Israel is considered a global leader in medical marijuana clinical trials and is one of the few countries with a government-sponsored medical cannabis program.
Major Players in Israel’s Cannabis Industry
- Tikun Olam – Founded in 2006, Tikun Olam is Israel’s first and largest supplier of medical cannabis. The company is a pioneer in research and development, producing a wide variety of cannabis strains and products for patients.
- Teva Pharmaceuticals – A global pharmaceutical giant, Teva entered into a distribution and cooperation agreement with Canndoc, an Israeli medical marijuana company, to distribute Canndoc’s GMP (Good Manufacturing Practice) products to pharma customers, including hospitals, health maintenance organizations (HMOs), and all Israeli pharmacies.
- Canndoc/InterCure – Canndoc is one of the first licensed cannabis producers in Israel and has been a leader in pharmaceutical-grade cannabis for over a decade. In recent years, InterCure has acquired Canndoc, making it one of the prominent forces in the Israeli cannabis market.
- Together Pharma – Specializing in the development, production, and marketing of medical cannabis and its products, Together Pharma operates under the highest quality standards and has made significant strides in the global market.
- BOL (Breath of Life) Pharma – BOL is one of the largest cannabis producers in Israel, with a wide range of products for medical cannabis patients. It is also known for its large extraction facility that produces cannabis isolates and oils.
- iCAN – iCAN is a cannabis innovation hub based in Israel, which hosts CannaTech, an international cannabis conference. iCAN focuses on identifying, funding, and incubating cannabis technologies and supporting global industry growth.
These key players in the Israeli cannabis industry are deeply involved in all aspects of the business, from cultivation and pharmaceutical production to R&D and global export. Additionally, there are numerous startups and mid-size companies making inroads into the cannabis tech space, with innovations in cultivation technology, delivery systems, and more.
The Israeli cannabis industry is poised for significant growth, especially in the area of medical cannabis exports, as international interest in the therapeutic potential of cannabis continues to grow and regulations around the world become more conducive to trade in this sector.
Israel is a global leader in the field of medical cannabis research and biotechnology. The country’s favorable government policies, advanced agricultural technology, and robust scientific community have contributed to its unique position in the cannabis industry.
The groundbreaking research of Prof. Raphael Mechoulam from the Hebrew University of Jerusalem, who was the first to isolate THC, the psychoactive compound in cannabis, laid the groundwork for the burgeoning medical cannabis industry in Israel.
The Israeli government has progressively taken steps to decriminalize cannabis and support medical cannabis research and business initiatives. In 2016, the government approved new regulations to ease the restrictions on growing, manufacturing, and exporting medical cannabis, opening up international business prospects for Israeli companies.
Israel’s Ministry of Health oversees the medical cannabis unit, which is responsible for patients’ licensing and regulation of the medical cannabis industry. Israel is considered a global leader in medical marijuana clinical trials and is one of the few countries with a government-sponsored medical cannabis program.
Major players in Israel’s cannabis industry include Tikun Olam, Teva Pharmaceuticals, Canndoc/InterCure, Together Pharma, BOL (Breath of Life) Pharma, and iCAN. These companies are deeply involved in all aspects of the business, from cultivation and pharmaceutical production to R&D and global export.
The Israeli cannabis industry is poised for significant growth, especially in the area of medical cannabis exports, as international interest in the therapeutic potential of cannabis continues to grow and regulations around the world become more conducive to trade in this sector.
Please note that these are external websites and I recommend visiting them for the most accurate and up-to-date information. Is there anything else you would like to know? I’m here to help! 😊
Learn more:
1. tikunolam.com2. tevapharm.com3. canndoc.com4. together-pharma.com5. bolpharma.com6. icanw.org7. tikuneurope.com8. tikunolam.com9. tikun-olam.info10. tevauk.com11. tevapharm.com12. intercure.co13. intercure.co14. togetherhealth.co.uk15. gsk.com16. bolpharma.com17. finder.startupnationcentral.org18. icanig.org19. icanig.org20. ican.org.uk21. en.ican.org.np22. intercure.co23. bolpharma.com